Dr. Hosam Elbaz is currently a research fellow at the University of Michigan, Ann Arbor. He graduated from Misr International University, college of pharmacy in June 2005. He then received his PhD from West Virginia University School of Pharmacy in December 2011, and then he finished a two-year postdoctoral fellowship at Wayne State University School of Medicine on March 2014. He is interested in experimental cancer therapeutics, particularly those derived from nutritional origins. He recently published a research article titled “Epicatechin Stimulates Mitochondrial Activity and Selectively Sensitizes Cancer Cells to Radiation” in which he showed that Epicatechin, a natural ingredient of coffee and dark chocolate, can increase the sensitivity of cancer cells to conventional radiotherapy while non-cancerous tissues remain unharmed. He showed that increasing mitochondrial respiration in cancer cells renders them sensitive to cell death by radiation. He is also serving as an Editorial member for several journals and he is a Member of American Society of Pharmacology and Experimental Therapeutics (ASPET), American Association of Pharmaceutical Scientists (AAPS), American Chemical Society (ACS), Egyptian General Syndicate of Pharmacists, and Golden Key International Honor Society.

Cancer Biology and Therapeutics; Carcinogenesis and Mutagenesis; Pharmacology and Toxicology; Preclinical Development.